SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- The global 3D cell culture market size is expected to reach USD 3.31 billion by 2030, expanding at 11.04% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.
Key Industry Insights & Findings from the report:
- The scaffold-based technology segment dominated the market in 2022 with a revenue share of 48.85% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications.
- Stem cell research & tissue engineering held the largest share of 33.76% in 2022, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research.
- In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share of 46.34%. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies.
- North America region dominated the global market in 2022 with a revenue share of 45.58%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them.
Read 150-page market research report, "3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Cancer, Drug Development), By End-use, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research.
3D Cell Culture Market Growth & Trends
Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in August 2021, Amerigo Scientific launched its 3D cell culture products for research purposes with wide applications in medicine, drug discovery, and tissue engineering.
In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2020, CELLINK and Lonza collaborated to offer 3D bioprinting solutions to optimize access to 3-dimensional cell cultures workflows.
3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds.
Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.
3D Cell Culture Market Report Scope
Report Attribute | Details |
Market size value in 2023 | USD 1.59 billion |
Revenue forecast in 2030 | USD 3.31 billion |
Growth rate | CAGR of 11.04% from 2023 to 2030 |
Base year for estimation | 2022 |
Historical data | 2018 - 2021 |
Forecast period | 2023 - 2030 |
3D Cell Culture Market Segmentation
Grand View Research has segmented the global 3D cell culture market based on technology, application, end-use, and region
3D Cell Culture Market - Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA Coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
3D Cell Culture Market - Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
3D Cell Culture Market - End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
3D Cell Culture Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Norway
- Sweden
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in the 3D Cell Culture Market
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- PromoCell GmbH
- Lonza
- Corning Incorporated
- Avantor, Inc.
- Tecan Trading AG
- REPROCELL Inc.
- CN Bio Innovations Ltd
- Lena Biosciences
Check out more related studies published by Grand View Research:
- Bioprocess Bags Market - The global bioprocess bags market size is expected to reach USD 10.21 billion by 2030, expanding at a CAGR of 17.14% from 2023 to 2030, according to a new report by Grand View Research, Inc. One of the primary drivers of growth in this market is the growing trend towards personalized medicine, the rising focus on sustainability in the pharmaceutical industry, and the increasing adoption of single-use bioprocessing technologies.
- Cell Culture Market - The global cell culture market size is expected to reach USD 60.27 billion by 2030, expanding at a CAGR of 11.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increase in biopharmaceutical production, advancements in vaccine research and development, and increasing focus on genetic engineering applications that rely heavily on cell culture techniques.
- 3D Printed Drugs Market - The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.
Browse through Grand View Research's Biotechnology Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/3d-cell-culture-market-to-reach-3-31-billion-by-2030-grand-view-research-inc-301875133.html
Voltar noticias em Inglês